← Back to all trials
Completed
NCT00439686
Study of ZIO-201 in Advanced Sarcoma
Conditions: Advanced Sarcoma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 54
Sponsor: Alaunos Therapeutics
Location: Santa Monica California
Summary
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.
Eligibility Criteria
Metastatic and /or unresectable disease state after previous standard chemotherapy
Source: ClinicalTrials.gov (NCT00439686). StuddyBuddy aggregates publicly available trial information.